Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,234 | 49,039 | 47,697 | 58,979 | 58,868 |
| Marketable Securities | 369,095 | 424,266 | 404,718 | 408,831 | 409,044 |
| Receivables | 114,585 | 107,188 | 98,117 | 92,965 | 105,555 |
| Inventories | 149,612 | 152,441 | 161,661 | 153,893 | 157,937 |
| TOTAL | $724,491 | $752,826 | $733,388 | $735,193 | $747,989 |
| Non-Current Assets | |||||
| PPE Net | 78,150 | 81,064 | 78,626 | 77,530 | 76,542 |
| Investments And Advances | 74,545 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 90,472 | 123,840 | 125,489 | 128,322 | 128,127 |
| TOTAL | $243,167 | $204,904 | $204,115 | $205,852 | $204,669 |
| Total Assets | $967,658 | $957,730 | $937,503 | $941,045 | $952,658 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 44,730 | 48,754 | 47,776 | 48,143 | 49,586 |
| Accrued Expenses | 18,170 | 12,280 | 13,225 | 10,932 | 12,726 |
| Other current liabilities | 49,312 | 38,319 | 34,208 | 30,338 | 28,462 |
| TOTAL | $247,049 | $259,276 | $240,610 | $192,971 | $195,258 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,831 | 42,567 | 44,200 | 44,562 | 43,994 |
| Other Non-Current Liabilities | 447,056 | 449,548 | 451,282 | 492,711 | 430,437 |
| TOTAL | $457,511 | $460,744 | $463,018 | $505,010 | $443,768 |
| Total Liabilities | $704,560 | $720,020 | $703,628 | $697,981 | $639,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,473 | 65,677 | 65,465 | 64,590 | 65,631 |
| Common Shares | 66 | 66 | 65 | 65 | 66 |
| Retained earnings | -1,047,825 | -1,048,580 | -1,025,329 | -994,515 | -951,800 |
| Other shareholders' equity | -1,947 | 3,870 | -1,253 | -935 | 1,369 |
| TOTAL | $263,098 | $237,710 | $233,875 | $243,064 | $313,632 |
| Total Liabilities And Equity | $967,658 | $957,730 | $937,503 | $941,045 | $952,658 |